Bengaluru, 23 October, 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as ...
Ahmedabad: Zydus Lifesciences Limited has announced that it has received in principle acceptability from World Health ...
Zydus Lifesciences advanced 1.71% to Rs 1,005.05 after the company received in principle acceptability from World Health Organisation (WHO) for its ZyVac TCV vaccine.
Zydus Lifesciences' shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, ...
Indian multinational pharmaceutical company Zydus Lifesciences Ltd on Wednesday announced that its Typhoid Vi conjugate ...
As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile illness and ...
Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV.
Dr Ayobami Alabi, a consultant paediatrician at the Ladoke Akintola University of Technology Teaching Hospital, says in this interview with SADE OGUNTOLA, ...
The salmonella outbreak is the 10th instance of gastrointestinal illness on cruises the CDC has documented in 2024. Of the other nine, seven were caused by norovirus, one was E. coli and the other ...